HHS Secretary nominee Tom Price refutes accusations of improper stock buys
January 18, 2017 at 15:30 PM EST
Shares of a medical device maker and a small Australian biotech were a key focus of a Wednesday hearing.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.